NCT01629784
Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus No drug interventions Not Available Not Available completed NCT06015737
A 2-stage, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus treatment 3 recruiting NCT01470313
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus No drug interventions treatment 1 terminated NCT03260166
Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus Erythematosus treatment 2 unknown_status NCT00420173
Interdisciplinary Study Group of Lupus Erythematosus (ISGLE) No drug interventions Not Available Not Available completed NCT00317681
Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE) treatment 2 completed NCT04809623
Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE) treatment 1 terminated NCT01776190
Low-dose UVA1 Radiation in Cutaneous Lupus Patients No drug interventions treatment Not Available completed NCT00523588
Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser No drug interventions treatment 2 completed NCT01498406
Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus No drug interventions treatment 2 terminated NCT06411106
Deep Phenotyping of Cutaneous Lupus Erythematosus other Not Available recruiting NCT01841619
IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus No drug interventions treatment 0 completed NCT03817424
A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis treatment 1 completed NCT04781816
Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus treatment 2 completed NCT03134222
Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE) treatment 2 completed NCT01146444
Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE) No drug interventions prevention Not Available completed NCT00470912
Sunscreen RV 2457C in Photoinduced CLE No drug interventions prevention 3 completed NCT01300208
To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus No drug interventions treatment 2 completed NCT04647708
Study of M5049 in CLE and SLE Participants No drug interventions treatment 1 completed NCT01510067
Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus No drug interventions Not Available Not Available recruiting NCT00633945
Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE) treatment Not Available completed NCT05411016
A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus No drug interventions treatment 1 recruiting NCT05629208
Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE) No drug interventions treatment 2 recruiting NCT00420121
European Society of Cutaneous Lupus Erythematosus (EUSCLE) No drug interventions Not Available Not Available unknown_status NCT00222183
Cutaneous Lupus Erythematosus and Elidel treatment Not Available withdrawn NCT01352988
Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus treatment 2 completed NCT02428309
Autologous Polyclonal Tregs for Lupus No drug interventions treatment 1 terminated NCT05879718
A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms. treatment 2 recruiting NCT04493541
A Study to Assess the Safety and Drug Levels of BMS-986256 in Participants With Active Cutaneous Lupus Erythematosus treatment 1 completed NCT04707924
Efficacy of Fractional Er:YAG Laser in Lupus Erythematosus Scars No drug interventions treatment Not Available withdrawn NCT02927457
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus Subjects No drug interventions treatment 1 completed NCT01559155
Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid No drug interventions Not Available Not Available terminated NCT01407679
Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus treatment 2 terminated NCT01923415
A Non-drug Study Profiling Cutaneous Lupus No drug interventions Not Available Not Available completed NCT02656082
Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus treatment 2 completed NCT02034344
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers No drug interventions Not Available Not Available completed NCT01702740
A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus No drug interventions treatment 1 completed NCT01845740
Phase Ib Study of SC Milatuzumab in SLE treatment 1 completed